While ERS was increased following dual MEK‐PI3K therapy, the degree of ERS aggravation may not have been sufficient to drive apoptosis and/or MAPK/PI3K‐mediated escape mechanisms may have protected cancer cells from ERS‐mediated apoptosis. This evidence concerns the gene MAP2K7 and cancer.